Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response.
Journal
medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986
Informations de publication
Date de publication:
16 Nov 2020
16 Nov 2020
Historique:
entrez:
25
11
2020
pubmed:
26
11
2020
medline:
26
11
2020
Statut:
epublish
Résumé
To determine clinical and ethnodemographic correlates of serological responses against the SARS-CoV-2 spike glycoprotein following mild-to-moderate COVID-19. A retrospective cohort study of healthcare workers who had self-isolated due to COVID-19. University Hospitals Birmingham NHS Foundation Trust, UK (UHBFT). 956 health care workers were recruited by open invitation via UHBFT trust email and social media. Participants volunteered a venous blood sample that was tested for the presence of anti-SARS-CoV-2 spike glycoprotein antibodies. Results were interpreted in the context of the symptoms of their original illness and ethnodemographic variables. Using an assay that simultaneously measures the combined IgG, IgA and IgM response against the spike glycoprotein (IgGAM), the overall seroprevalence within this cohort was 46.2% (n=442/956). The seroprevalence of immunoglobulin isotypes was 36.3%, 18.7% and 8.1% for IgG, IgA and IgM respectively. IgGAM identified serological responses in 40.6% (n=52/128) of symptomatic individuals who reported a negative SARS-CoV-2 PCR test. Increasing age, non-white ethnicity and obesity were independently associated with greater IgG antibody response against the spike glycoprotein. Self-reported fever and fatigue were associated with greater IgG and IgA responses against the spike glycoprotein. The combination of fever and/or cough and/or anosmia had a positive predictive value of 92.3% for seropositivity. Assays employing combined antibody detection demonstrate enhanced seroepidemiological sensitivity and can detect prior viral exposure even when PCR swabs have been negative. We demonstrate an association between known ethnodemographic risk factors associated with mortality from COVID-19 and the magnitude of serological responses in mild-to-moderate disease. The combination of cough, and/or fever and/or anosmia identifies the majority of individuals who should self-isolate for COVID-19.
Identifiants
pubmed: 33236029
doi: 10.1101/2020.11.12.20230763
pmc: PMC7685342
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : Medical Research Council
ID : MC_PC_17183
Pays : United Kingdom
Commentaires et corrections
Type : UpdateIn
Références
Cell Rep Med. 2020 Aug 25;1(5):100078
pubmed: 32838342
Immun Ageing. 2019 Sep 13;16:25
pubmed: 31528180
Front Public Health. 2020 Jul 28;8:418
pubmed: 32850607
Science. 2020 Oct 23;370(6515):
pubmed: 32972996
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
J Exp Med. 2019 Sep 2;216(9):1986-1998
pubmed: 31235509
JAMA. 2020 May 12;323(18):1843-1844
pubmed: 32159775
JAMA. 1999 Dec 8;282(22):2131-5
pubmed: 10591334
Clin Infect Dis. 2020 Nov 19;71(16):2027-2034
pubmed: 32221519
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
Blood Cancer J. 2020 Apr 28;10(4):44
pubmed: 32345975
Nat Rev Immunol. 2019 Sep;19(9):563-572
pubmed: 31175337
Elife. 2020 Aug 21;9:
pubmed: 32820721
Circulation. 2020 Jul 7;142(1):4-6
pubmed: 32320270
Thorax. 2020 Dec;75(12):1089-1094
pubmed: 32917840
Nat Med. 2020 Jun;26(6):845-848
pubmed: 32350462
Thorax. 2021 Jan;76(1):61-63
pubmed: 32963115
J Exp Med. 2009 Jan 16;206(1):69-78
pubmed: 19139170
Clin Vaccine Immunol. 2016 Apr 04;23(4):379-85
pubmed: 26912783
BMJ. 2020 Sep 3;370:m3364
pubmed: 32883673
Science. 2020 Oct 16;370(6514):303-304
pubmed: 33020250
Lancet. 2020 Jul 25;396(10246):e6-e7
pubmed: 32653078
Nat Med. 2020 Oct;26(10):1623-1635
pubmed: 32807934
J Clin Endocrinol Metab. 1997 Dec;82(12):4196-200
pubmed: 9398739
Nature. 2020 Aug;584(7821):463-469
pubmed: 32717743
Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):7881-5
pubmed: 20385827
PLoS One. 2019 Dec 11;14(12):e0225512
pubmed: 31825961
Clin Infect Dis. 1999 Aug;29(2):281-8
pubmed: 10476727
Science. 2020 Jul 17;369(6501):330-333
pubmed: 32366695
Clin Infect Dis. 2021 Mar 15;72(6):1064-1066
pubmed: 32584972
J Allergy Clin Immunol. 2021 Jan;147(1):72-80.e8
pubmed: 33010257
BMJ. 2020 May 22;369:m1985
pubmed: 32444460